Serological and Molecular Testing in Hepatitis B and the Dialysis Patient

Lee W.M. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733–45.

Mast E.E. , Mahoney F.J. , Alter M.J. , Margolis H.S. Progress towards elimination of hepatitis B virus transmission in the United States. Vaccine 1998; 16(suppl): S48–51.

Mast E.E. , Willams I.T. , Alter M.J. , Margolis H.S. Hepatitis B vaccination of adolescent and adult high-risk groups in the United States. Vaccine 1998; 16(suppl): S27–9.

McQuillan G.M. , Coleman P.J. , Kruszon-Moran D. , Moyer L.A. , Lambert S.B. , Margolis H.S. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89: 14–8.

Fabrizi F. , Martin P. , Lunghi G. , Ponticelli C. Novel evidence on hepatitis B virus infection in dialysis. Int J Artif Organs 2001; 24: 8–16.

Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50(No RR-5): 1–43.

Weston S.R. , Martin P. Serological and molecular testing in viral hepatitis: an update. Can J Gastroenterol 2001; 15: 177–84.

Martin P. , Friedman L.S. , Dienstag J.L. Diagnostic approach. In: Zuckerman A.J. , Thomas H.C. , eds. Viral hepatitis: Scientific basis and clinical management. London: Churchill Livingston, 1993; 393–410.

Fabrizi F. , Di Filippo S. , Marcelli D. . Recombinant hepatitis B vaccine in chronic hemodialysis patients: long-term evaluation and cost-effectiveness analysis. Nephron 1996; 72: 536–43.

Wachs M.E. , Amend W.J. , Ascher N.L. . The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59: 230–4.

Uemoto S. , Sugiyama K. , Marusawa H. . Transmission of hepatitis B virus from hepatitis B core antibody positive donors in living related liver transplants. Transplantation 1998; 65: 494–9.

Marcellin P. , Giostra E. , Martinot-Peignoux M. . Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100: 1432–4.

Sjogren M.H. Serological diagnosis of viral hepatitis. Med Clin North Am 1996; 80: 929–56.

Janzen L. , Minuk G.Y. , Fast M. , Bernstein K.N. Vaccine induced hepatitis B surface antigen positivity in adult hemodialysis patients: Incidental and surveillance data. J Am Soc Nephrol 1996; 7: 1228–34.

Riley S. , Tong C.Y.W. , Rutherford P.A. Spurious hepatitis B surface antigen detection in a haemodialysis patient (letter). Nephrol Dial Transplant 1998; 13: 1897–8.

Brodersen H.P. , Beckers B. , Kohler H. , Dahlmanns C. , Kruska L. , Larbig D. The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine (letter). Nephrol Dial Transplant 1997; 12: 2756–7.

Scotto J. , Hadchouel M. , Hery C. , Yvart J. , Tiollais P. , Brechot C. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology 1983; 3: 279–84.

Berninger M. , Hammer M. , Hoyer B. , Gerin J.L. An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol 1982; 9: 57–68.

Kuhns M.C. , McNamara A.L. , Cabal C.M. . A new assay for the quantitative detetction of hepatitis B viral DNA in human serum. In: Zukerman A.J. , ed. Viral hepatitis and liver disease. New York: A.R. Liss, 1988: 258–62.

Digene Technical Bulletin. Manufacturing Procedure for Digene HBV-DNA Standards and Interpretation of Resulting Picogram Levels in the Hybrid Capture HBV-DNA Assay. Silver Springs, MA, USA.

Urdea M.S. , Kolberg J. , Warner B.D. , Horn T. , Clyne J. , Ku L. , Running J.A. A novel method for the rapid detection of hepatitis B virus in human serum samples without blotting or radioactivity. In: Knox Van Dyke , ed. Luminescence immunoassay and molecular applications. Boston: CRC Press, 1990; 275–92.

Butterworth L.A. , Prior S.L. , Buda P.J. , Faoagali J.L. , Cooksley W.G.E. Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J Hepatol 1996; 24: 686–91.

Lehtovaara P. , Uusi-Oukari M. , Laaksonen M. , Bengtstrom M. , Ranki M. Quantitative PCR for hepatitis B virus with colorimetric detection. PCR Methods Appl 1993; 3: 169–75.

DiDomenico N. , Link H. , Knobel R. . Cobas Amplicor^™: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. Clin Chem 1996; 42: 1915–23.

Noborg U. , Gusdal A. , Pisa E.K. , Hedrum A. , Lindh M. Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV Monitor Test. J Clin Microbiol 1999; 37: 2793–7.

Krajden M. , Minor J. , Cork L. , Comanor L. Multi-measurement method comparison of three commercial hepatitis B virus DNA quantification assays. J Viral Hepatol 1998; 5: 415–22.

Perrillo R.P. , Schiff E.R. , Davis G.L. , Bodenheimer H.C. , Lindsay K. , Payne J. , Dienstag J.L. , O'Brien C. , Tamburro C. , Jacobson I.M. , Sampliner R. , Felt D. , Lefkowitch J. , Kuhns M. , Meschievitz C. , Sanghvi B. , Albrecht J. , Gibas A. , and The Hepatitis Interventional Therapy Group. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295–301.

Niesters H.G.M. , Krajden M. , Cork L. . A multicenter study evaluation of the Digene Hybrid Capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of Eurohep standards. J Clin Microbiol 2000; 38: 2150–5.

Gerken G. , Gomes J. , Lampertico P. . Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 1998; 74: 155–65.

Pawlotsky J.M. , Bastie A. , Hezode C. . Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods 2000; 85: 11–21.

Hadziyannis S.L. , Manesis E.K. , Papakonstantinou A. Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study. J Hepatol 1999; 31: 210–4.

Perrillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120: 1009–22.

Hoofnagle J.H. , Dusheiko G.M. , Schafer D.F. . Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 447–9.

Lok A.S.F. , Liang R.H.S. , Chiu E.K.W. , Wong K.L. , Chan T.K. , Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182–8.

Rehermann B. , Ferrari C. , Pasquinelli C. , Chisari F.V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104–8.

Fong T.L. , Di Bisceglie A.M. , Gerber M.A. , Waggoner J.G. , Hoofnagle J.H. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993; 18: 1313–8.

Blackberg J. , Kidd-Ljungren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 33: 992–7.

Conjeevaram H.S. , Lok A. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34: 204–6.

Brechot C. , Thiers V. , Kremsdorf D. , Nalpas B. , Pol S. , Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely ‘occult’? Hepatology 2001; 3: 194–203.

Thiers V. , Kremsdorf D. , Schellekens H. . Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988; 2: 1273–6.

Lok A.S.F. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32(suppl): S89–97.

Lok A.S.F. , Heathcote E.J. , Hoofnagle J.H. Management of hepatitis B: 2000– Summary of a workshop. Gastroenterology 2001; 120: 1828–53.

Pao C.C. , Yang W.L. , Huang C.C. . Hepatitis type B virus DNA in patients receiving hemodialysis: correlation with other serological markers. Nephron 1987; 46: 155–60.

Dueymes J.M. , Bodenes-Dueymes M. , Mahè J.L. , Herman B. Detection of hepatitis B viral DNA by polymerase chain reaction in dialysis patients. Kidney Int 1993; 41(suppl): S161–6.

Oesterreicher C. , Hammer J. , Koch U. . HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995; 48: 1967–71.

Fabrizi F. , Martin P. , Dixit V. . Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron 1998; 80: 428–33.

Bukh J. , Wantzin P. , Krogsgaard K. , Knudsen F. , Purcell R.H. , Miller R.H. , and The Copenhagen Dialysis HCV Study Group. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993; 168: 1343–8.

Cabrerizo M. , Bartolomé J. , De Sequera P. , Caramelo C. , Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 1997; 8: 1443–7.

Martin P. , Friedman L.S. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995; 47: 1231–41.

Farza H. , Salmon A.M. , Hadchouel M. . Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci 1987; 84: 1187–91.